Literature DB >> 2991963

Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.

P J Cowen, H Gadhvi, B Gosden, T Kolakowska.   

Abstract

Intravenous infusion of L-tryptophan (LTP) in 18 normal subjects produced a significant increase in plasma prolactin (PRL), growth hormone (GH), and self-ratings of drowsiness. There was no correlation between the PRL and GH responses, or between the hormonal responses and drowsiness. Saline infusion did not result in endocrine or psychological changes. The effect of LTP on both PRL and GH was dose-related in that LTP 7.5 g produced greater endocrine responses than 5.0 g. It was not significantly decreased by cyproheptadine, a 5-HT receptor antagonist. Schizophrenic patients receiving neuroleptics had increased PRL response to LTP, possibly because of the drug-induced disinhibition of PRL release. Their GH response to LTP was markedly decreased. The mechanism of this effect requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991963     DOI: 10.1007/bf00431703

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion.

Authors:  P D Woolf; L Lee
Journal:  J Clin Endocrinol Metab       Date:  1977-07       Impact factor: 5.958

2.  Lack of effects of L-tryptophan on basal and TRH-stimulated TSH and prolactin levels.

Authors:  J Faber; C Hagen; C Kirkegaard; U B Lauridsen; S E Møller
Journal:  Psychoneuroendocrinology       Date:  1977-10       Impact factor: 4.905

3.  Release of ( 3 H)dopamine by L-5-hydroxytryptophan.

Authors:  L K Ng; T N Chase; R W Colburn; I J Kopin
Journal:  Brain Res       Date:  1972-10-27       Impact factor: 3.252

4.  Autonomous prolactin secretion in schizophrenic male on long-term neuroleptic therapy.

Authors:  C G Semple; J A Thomson; G H Beastall; S F Whyte
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

5.  Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.

Authors:  I Lancranjan; A Wirz-Justice; W Pühringer; E Del Pozo
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

6.  Effects of thyrotropin-releasing hormone and metoclopramide in patients with phenothiazine-induced hyperprolactinemia.

Authors:  H V Lankford; W G Blackard; D F Gardner; H S Tucker
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

7.  Effect of chlorpromazine on human growth hormone.

Authors:  A A Beg; V K Varma; R J Dash
Journal:  Am J Psychiatry       Date:  1979-07       Impact factor: 18.112

8.  Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.

Authors:  T Kolakowska; M Gelder; S Fraser
Journal:  Br J Psychiatry       Date:  1981-11       Impact factor: 9.319

9.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

Authors:  G R Heninger; D S Charney; D E Sternberg
Journal:  Arch Gen Psychiatry       Date:  1984-04

10.  Suppression of human growth hormone secretion by melatonin and cyproheptadine.

Authors:  G A Smythe; L Lazarus
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  8 in total

1.  The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.

Authors:  P W Glue; P J Cowen; D J Nutt; T Kolakowska; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan.

Authors:  C Idzikowski; P J Cowen; D Nutt; F J Mills
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.

Authors:  I M Anderson; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  The effects of gepirone on neuroendocrine function and temperature in humans.

Authors:  I M Anderson; P J Cowen; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Acute administration of nutritionally sourced tryptophan increases fear recognition.

Authors:  M-J Attenburrow; C Williams; J Odontiadis; A Reed; J Powell; P J Cowen; C J Harmer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-29       Impact factor: 4.530

6.  Effect of the 5-HT1A partial agonist buspirone on regional cerebral blood flow in man.

Authors:  P M Grasby; K J Friston; C Bench; P J Cowen; C D Frith; P F Liddle; R S Frackowiak; R J Dolan
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Modelling anxiety in humans for drug development.

Authors:  Martin Siepmann; Peter Joraschky
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

Review 8.  Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.